180 related articles for article (PubMed ID: 19734846)
21. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
[TBL] [Abstract][Full Text] [Related]
22. [Matrix gene expression pattern as indicators of the biology of cartilage-forming tumors].
Aigner T; Unni CC; Bjornsson J; Kirchner T
Verh Dtsch Ges Pathol; 1998; 82():178-83. PubMed ID: 10095430
[TBL] [Abstract][Full Text] [Related]
23. [Dedifferentiated chondrosarcoma: radiologic-pathologic correlation].
Bierry G; Feydy A; Larousserie F; Pluot E; Guerini H; Campagna R; Dufau-Andreu C; Anract P; Babinet A; Dietemann JL; Chevrot A; Drapé JL
J Radiol; 2010 Mar; 91(3 Pt 1):271-9. PubMed ID: 20508557
[TBL] [Abstract][Full Text] [Related]
24. Dedifferentiated peripheral chondrosarcomas. A report of seven cases.
Bertoni F; Present D; Bacchini P; Picci P; Pignatti G; Gherlinzoni F; Campanacci M
Cancer; 1989 May; 63(10):2054-9. PubMed ID: 2702574
[TBL] [Abstract][Full Text] [Related]
25. Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma.
Schrage YM; Hameetman L; Szuhai K; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
Am J Pathol; 2009 Mar; 174(3):979-88. PubMed ID: 19179614
[TBL] [Abstract][Full Text] [Related]
26. Towards a new understanding and classification of chondrogenic neoplasias of the skeleton--biochemistry and cell biology of chondrosarcoma and its variants.
Aigner T
Virchows Arch; 2002 Sep; 441(3):219-30. PubMed ID: 12242518
[TBL] [Abstract][Full Text] [Related]
27. Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas.
Aigner T; Müller S; Neureiter D; Illstrup DM; Kirchner T; Björnsson J
Cancer; 2002 Apr; 94(8):2273-81. PubMed ID: 12001127
[TBL] [Abstract][Full Text] [Related]
28. Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas.
Rozeman LB; Hameetman L; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
J Pathol; 2005 Mar; 205(4):476-82. PubMed ID: 15685701
[TBL] [Abstract][Full Text] [Related]
29. p53 expression and DNA ploidy of cartilage lesions.
Coughlan B; Feliz A; Ishida T; Czerniak B; Dorfman HD
Hum Pathol; 1995 Jun; 26(6):620-4. PubMed ID: 7774891
[TBL] [Abstract][Full Text] [Related]
30. Co-expression of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP receptor in cartilaginous tumours: a marker for malignancy?
Kunisada T; Moseley JM; Slavin JL; Martin TJ; Choong PF
Pathology; 2002 Apr; 34(2):133-7. PubMed ID: 12009094
[TBL] [Abstract][Full Text] [Related]
31. Expression of cartilage growth plate signalling molecules in chondroblastoma.
Romeo S; Bovée JV; Jadnanansing NA; Taminiau AH; Hogendoorn PC
J Pathol; 2004 Jan; 202(1):113-20. PubMed ID: 14694528
[TBL] [Abstract][Full Text] [Related]
32. MRI differentiation of low-grade from high-grade appendicular chondrosarcoma.
Douis H; Singh L; Saifuddin A
Eur Radiol; 2014 Jan; 24(1):232-40. PubMed ID: 24337911
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of a dedifferentiated chondrosarcoma of the pelvis by fine needle aspiration. A case report.
Estrada-Villaseñor E; Rico-Martínez G; Linares-Gonzalez LM
Acta Cytol; 2010; 54(2):217-20. PubMed ID: 20391984
[TBL] [Abstract][Full Text] [Related]
34. cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.
Rozeman LB; Hameetman L; van Wezel T; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2005 Sep; 207(1):61-71. PubMed ID: 16007578
[TBL] [Abstract][Full Text] [Related]
35. Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma.
Meijer D; de Jong D; Pansuriya TC; van den Akker BE; Picci P; Szuhai K; Bovée JV
Genes Chromosomes Cancer; 2012 Oct; 51(10):899-909. PubMed ID: 22674453
[TBL] [Abstract][Full Text] [Related]
36. Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings.
Kim JH; Lee SK
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980590
[TBL] [Abstract][Full Text] [Related]
37. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.
de Andrea CE; Reijnders CM; Kroon HM; de Jong D; Hogendoorn PC; Szuhai K; Bovée JV
Oncogene; 2012 Mar; 31(9):1095-104. PubMed ID: 21804604
[TBL] [Abstract][Full Text] [Related]
38. [Dedifferentiated chondrosarcoma. A study of 13 clinical cases and review of the literature].
Anract P; Tomeno B; Forest M
Rev Chir Orthop Reparatrice Appar Mot; 1994; 80(8):669-80. PubMed ID: 7638395
[TBL] [Abstract][Full Text] [Related]
39. New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance.
Monderer D; Luseau A; Bellec A; David E; Ponsolle S; Saiagh S; Bercegeay S; Piloquet P; Denis MG; Lodé L; Rédini F; Biger M; Heymann D; Heymann MF; Le Bot R; Gouin F; Blanchard F
Lab Invest; 2013 Oct; 93(10):1100-14. PubMed ID: 23958880
[TBL] [Abstract][Full Text] [Related]
40. Expression of insulin-like growth factor II mRNA binding protein 3 (IMP3) in enchondroma and chondrosarcoma.
Shooshtarizadeh T; Nazeri A; Zare-Mirzaie A; Movahedinia S
Pathol Res Pract; 2016 Apr; 212(4):335-9. PubMed ID: 26948096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]